FDA
-
-
-
-
-
-
-
Silo Pharma reports nine-month stability data for SPC-15 PTSD drug
-
-
-
-
-
-
-
Silo Pharma acquires AI platform Qwikagents to expand into AI agent market
-
-
-
-
-
-
-
Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program
-
-
-
-
-
-
-
Silo Pharma launches crypto treasury strategy with Bitcoin focus
-
-
-
-
-
-
-
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
-
-
-
-
-
-
-
Silo Pharma's (SILO) SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
-
-
-
-
-
-
-
Silo Pharma (SILO) Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment
-
328,875 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

